Immunological memory is a defining feature of the adaptive immune system. Memory T cells carry an Imprint from the previous antigen encounter for decades, which enables them to respond more vigorously and to develop effector functions more rapidly upon antigen recognition than naive T cells. Epigenetic mechanisms have been suspected to allow for more rapid gene activation and also maintain a response pattern that was originally developed on the first antigen encounter. With Increasing age the ability of the adaptive immune system to generate and maintain T cell memory is severely impaired compromising the efficacy of vaccination. In studies during the last funding period, we have identified negative feedback signaling loops that impair T cell responses in the elderly. Here, we propose to examine how these signaling pathways involving miR181a, AMPK and SIRTI regulate T effector and memory cell differentiation by controlling the activity of selected transcription factors and epigenetic imprinting. In four specific aims, we will perform mechanistic in vitro studies in parallel to correlative in vivo studies on antigen-specific T cells after yellow fever vaccination.
In Aim 1, we will further define the role of AMPK and SIRTI pathways for T cell expansion and differentiation in young and elderly adults and examine the relationship to the expression of miR181a that declines with age.
In Aim 2, we will explore how innate immunity and in particular type 1 IFN regulates these pathways and what the consequences are for the differentiation and survival of elderly CD4 T cells that have reduced sensitivity to respond to IFN.
In Aim 3, we will determine the consequences of AMPK and SIRT pathway activation after TCR stimulation for chromatin remodeling and transcription factor binding. We will use a novel multidimensional epigenomic assay that relies on in vitro transposition of sequencing tags Into regions of accessible chromatin and that allows mapping the open chromatin and foot-printing transcription factor binding in antigen-specific T cells.
In Aim 4, we will examine epigenetic signatures and miRNA profiles in CD28'effector T cells early after vaccination compare to CD28"""""""" T cells that arise with aging and chronic latent infections to explore whether these two populations are related or differ in the expression of genes involved in cell longevity and tissue residency.

Public Health Relevance

Induction of immune memory by vaccination is at the core of preventive medicine. Generation and maintenance of T cell memory declines with age rendering vaccination less efficacious. With the changing demographics of the US and world population, this age-related immune incompetence is a major health problem. This application proposes to examine the regulation of signaling pathways that are important in imprinting epigenetic signatures in memory cells and that are dysfunctional in the elderly.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
2U19AI057266-11
Application #
8724842
Study Section
Special Emphasis Panel (ZAI1)
Project Start
2014-05-01
Project End
2019-04-30
Budget Start
2014-05-01
Budget End
2015-04-30
Support Year
11
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Emory University
Department
Type
DUNS #
City
Atlanta
State
GA
Country
United States
Zip Code
Fang, Fengqin; Yu, Mingcan; Cavanagh, Mary M et al. (2016) Expression of CD39 on Activated T Cells Impairs their Survival in Older Individuals. Cell Rep 14:1218-31
Ravindran, Rajesh; Loebbermann, Jens; Nakaya, Helder I et al. (2016) The amino acid sensor GCN2 controls gut inflammation by inhibiting inflammasome activation. Nature 531:523-7
Chandele, Anmol; Sewatanon, Jaturong; Gunisetty, Sivaram et al. (2016) Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India. J Virol 90:11259-11278
Neu, Karlynn E; Henry Dunand, Carole J; Wilson, Patrick C (2016) Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease? Curr Opin Immunol 42:48-55
DiLillo, David J; Palese, Peter; Wilson, Patrick C et al. (2016) Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection. J Clin Invest 126:605-10
Henry Dunand, Carole J; Leon, Paul E; Huang, Min et al. (2016) Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection. Cell Host Microbe 19:800-13
Qi, Qian; Cavanagh, Mary M; Le Saux, Sabine et al. (2016) Diversification of the antigen-specific T cell receptor repertoire after varicella zoster vaccination. Sci Transl Med 8:332ra46
Ho, Irvin Y; Bunker, Jeffrey J; Erickson, Steven A et al. (2016) Refined protocol for generating monoclonal antibodies from single human and murine B cells. J Immunol Methods 438:67-70
Nakaya, Helder I; Clutterbuck, Elizabeth; Kazmin, Dmitri et al. (2016) Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood. Proc Natl Acad Sci U S A 113:1853-8
Burke, Rachel M; Suchdev, Parminder S; Rebolledo, Paulina A et al. (2016) Predictors of Inflammation in a Cohort of Bolivian Infants and Toddlers. Am J Trop Med Hyg 95:954-963

Showing the most recent 10 out of 202 publications